What the primary healthcare worker needs to know about the management of type 2 diabetes

Mollentze, W. F.
April 2012
South African Family Practice;Apr/May2012, Vol. 54 Issue 2, pS20
Academic Journal
The article discusses the clinical management of type 2 diabetes. All type 2 diabetic patients are advised to exercise regularly if there are no associated contraindications. The American Diabetes Association's (ADA) recommended approach to diabetes are metformin, lifestyle interventions and medical nutrition therapy. Both the use of insulin and insulin secretagogues can induce hypoglycemia. Aspirin is also recommended by the ADA for patients diabetics with a history of cardiovascular disease.


Related Articles

  • Diabetes mellitus and exercise. Herman, William H. // Clinical Diabetes;Fall99, Vol. 17 Issue 4, p156 

    Comments on the stance taken by the American Diabetes Association regarding diabetes mellitus and exercise. Description of ideal treatment for type 2 diabetes; Potential risks of exercise; Importance of health providers' awareness of the benefits and risks of a treatment.

  • Reshuffling the Medication Choices for Type 2 Diabetes. Scherger, Joseph E. // Internal Medicine Alert;12/15/2008, Vol. 30 Issue 23, p177 

    Leaders of the American Diabetes Association (ADA) joined with leaders of the European Association for the Study of Diabetes to reconsider the treatment strategy for patients with Type 2 diabetes. Insulin and sulfonylureas now join metformin as tier 1 medications. Tier 2 medications include the...

  • Colesevelam provides economic benefit in T2DM treatment.  // PharmacoEconomics & Outcomes News;7/11/2009, Issue 582, p4 

    The article discusses a study presented at the 69th Annual Scientific Sessions of the American Diabetes Association which revealed that the addition of colesevelam to a metformin-based regimen for type 2 diabetes mellitus (T2DM) increases glycaemic control and reduces Low Density...

  • GPs fail to follow guidelines on aspirin in type 2 diabetes patients. Bhattacharya, Shaoni // Pulse;6/17/2002, Vol. 62 Issue 24, p16 

    Focuses on the result of a survey conducted by the American Diabetes Association concerning the practice of physicians in prescribing aspirin to patients with type 2 diabetes. Volume of patients under aspirin medication as of September 2001; Effect of aspirin on diabetes patients.

  • Early Detection and Early Treatment May Lead to a Better Control of Type 2 Diabetes. Hattori, Masakazu; Chinen, Yosinao; Muto, Nozomu; Shimatsu, Akira; Oishi, Mariko; Basuki, Wanny; Hiromura, Makoto; Sakurai, Hiromu; Kuzuya, Hideshi // Diabetes;Jun2007 Supplement 1, Vol. 56, pA627 

    Aim: Our aims are to study the clinical course of type 2 diabetes and the importance of its early detection in the Japanese population. Methods: Type 2 diabetic Japanese patients (n=301) untreated for diabetes upon first visits to our clinic were registered in 1995 -2000, treated by diet,...

  • Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Yilmaz, Hamiyet; Gursoy, Alptekin; Sahin, Mustafa; Demirag, Nilgun Guvener // Acta Diabetologica;Dec2007, Vol. 44 Issue 4, p187 

    The aim of this study was to compare the efficacy of treatment with insulin alone, insulin plus acarbose, insulin plus metformin, or insulin plus rosiglitazone in type 2 diabetic subjects who were previously on insulin monotherapy, and to evaluate the effects of these treatments on...

  • Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir. DAVIES, MELANIE; HELLER, SIMON; SREENAN, SEAMUS; SAPIN, HÉLÈNE; ADETUNJI, OMOLARA; TAHBAZ, ARASH; VORA, JITEN // Diabetes Care;May2013, Vol. 36 Issue 5, p1368 

    OBJECTIVE--This multicenter, open-label, parallel-arm study compared the efficacy and safety of exenatide once weekly (EQW) with titrated insulin detemir in patients with type 2 diabetes inadequately controlled with metformin (with or without sulfonylureas). RESEARCH DESIGN AND METHODS--Patients...

  • Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin. RIDDLE, MATTHEW C.; ARONSON, RONNIE; HOME, PHILIP; MARRE, MICHEL; NIEMOELLER, ELISABETH; MIOSSEC, PATRICK; LIN PING; YE, JENNY; ROSENSTOCK, JULIO // Diabetes Care;Sep2013, Vol. 36 Issue 9, p2489 

    OBJECTIVE--To examine the efficacy and safety of adding the once-daily glucagon-like pep tide-1 receptor agonist (GLP-1RA) lixisenatide to established basal insulin therapy alone or together with metformin, in people with type 2 diabetes and elevated glycated hemoglobin (HbA1c). RESEARCH DESIGN...

  • Metformin and Exercise in Type 2 Diabetes. BOULÉ, NORMAND G.; ROBERT, CHERI; BELL, GORDON J.; JOHNSON, STEVEN T.; BELL, RHONDA C.; LEWANCZUK, RICHARD Z.; GABR, RANIAH Q.; BROCKS, DION R. // Diabetes Care;Jul2011, Vol. 34 Issue 7, p1469 

    OBJECTIVE--To determine the effect of metformin on the acute metabolic response to submaximal exercise, the effect of exercise on plasma metformin concentrations, and the interaction between metformin and exercise on the subsequent response to a standardized meal. RESEARCH DESIGN AND...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics